The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Diltiazem-Global Market Insights and Sales Trends 2025
Synopsis
Diltiazem is a nondihydropyridine (non-DHP) calcium channel blocker used in the treatment of hypertension, angina pectoris, and some types of arrhythmia. It relaxes the smooth muscles in the walls of arteries, which opens (dilates) the arteries, allows blood to flow more easily, and lowers blood pressure. Additionally, it lowers blood pressure by acting on the heart itself to reduce the rate, strength, and conduction speed of each beat.
The global Diltiazem market size is expected to reach US$ 505 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of Diltiazem in various end use industries. The expanding demands from the Angina and Hypertension, are propelling Diltiazem market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsule segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Diltiazem market, driven by demand from China, the second largest economy with some signs of stabilising, the Diltiazem market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diltiazem, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diltiazem market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diltiazem market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diltiazem sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diltiazem covered in this report include Bausch Health, Teva, Mylan, Athenex, Pfizer, Akorn, Sandoz, Sun Pharma and Hikma Pharmaceuticals, etc.
The global Diltiazem market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bausch Health
Teva
Mylan
Athenex
Pfizer
Akorn
Sandoz
Sun Pharma
Hikma Pharmaceuticals
Zydus Pharmaceuticals
Par Pharmaceutical
Global Diltiazem market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diltiazem market, Segment by Type:
Tablet
Capsule
Injection
Global Diltiazem market, by Application
Angina
Hypertension
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Diltiazem manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Diltiazem in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Diltiazem is a nondihydropyridine (non-DHP) calcium channel blocker used in the treatment of hypertension, angina pectoris, and some types of arrhythmia. It relaxes the smooth muscles in the walls of arteries, which opens (dilates) the arteries, allows blood to flow more easily, and lowers blood pressure. Additionally, it lowers blood pressure by acting on the heart itself to reduce the rate, strength, and conduction speed of each beat.
The global Diltiazem market size is expected to reach US$ 505 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of Diltiazem in various end use industries. The expanding demands from the Angina and Hypertension, are propelling Diltiazem market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsule segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Diltiazem market, driven by demand from China, the second largest economy with some signs of stabilising, the Diltiazem market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diltiazem, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diltiazem market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diltiazem market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diltiazem sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diltiazem covered in this report include Bausch Health, Teva, Mylan, Athenex, Pfizer, Akorn, Sandoz, Sun Pharma and Hikma Pharmaceuticals, etc.
The global Diltiazem market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bausch Health
Teva
Mylan
Athenex
Pfizer
Akorn
Sandoz
Sun Pharma
Hikma Pharmaceuticals
Zydus Pharmaceuticals
Par Pharmaceutical
Global Diltiazem market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diltiazem market, Segment by Type:
Tablet
Capsule
Injection
Global Diltiazem market, by Application
Angina
Hypertension
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Diltiazem manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Diltiazem in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Diltiazem Market Overview
1.1 Diltiazem Product Overview
1.2 Diltiazem Market Segment by Type
1.2.1 Tablet
1.2.2 Capsule
1.2.3 Injection
1.3 Global Diltiazem Market Size by Type
1.3.1 Global Diltiazem Market Size Overview by Type (2018-2029)
1.3.2 Global Diltiazem Historic Market Size Review by Type (2018-2023)
1.3.3 Global Diltiazem Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Diltiazem Sales Breakdown by Type (2018-2023)
1.4.2 Europe Diltiazem Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Diltiazem Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Diltiazem Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Diltiazem Sales Breakdown by Type (2018-2023)
2 Global Diltiazem Market Competition by Company
2.1 Global Top Players by Diltiazem Sales (2018-2023)
2.2 Global Top Players by Diltiazem Revenue (2018-2023)
2.3 Global Top Players by Diltiazem Price (2018-2023)
2.4 Global Top Manufacturers Diltiazem Manufacturing Base Distribution, Sales Area, Product Type
2.5 Diltiazem Market Competitive Situation and Trends
2.5.1 Diltiazem Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Diltiazem Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diltiazem as of 2022)
2.7 Date of Key Manufacturers Enter into Diltiazem Market
2.8 Key Manufacturers Diltiazem Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Diltiazem Status and Outlook by Region
3.1 Global Diltiazem Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Diltiazem Historic Market Size by Region
3.2.1 Global Diltiazem Sales in Volume by Region (2018-2023)
3.2.2 Global Diltiazem Sales in Value by Region (2018-2023)
3.2.3 Global Diltiazem Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Diltiazem Forecasted Market Size by Region
3.3.1 Global Diltiazem Sales in Volume by Region (2024-2029)
3.3.2 Global Diltiazem Sales in Value by Region (2024-2029)
3.3.3 Global Diltiazem Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Diltiazem by Application
4.1 Diltiazem Market Segment by Application
4.1.1 Angina
4.1.2 Hypertension
4.2 Global Diltiazem Market Size by Application
4.2.1 Global Diltiazem Market Size Overview by Application (2018-2029)
4.2.2 Global Diltiazem Historic Market Size Review by Application (2018-2023)
4.2.3 Global Diltiazem Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Diltiazem Sales Breakdown by Application (2018-2023)
4.3.2 Europe Diltiazem Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Diltiazem Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Diltiazem Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Diltiazem Sales Breakdown by Application (2018-2023)
5 North America Diltiazem by Country
5.1 North America Diltiazem Historic Market Size by Country
5.1.1 North America Diltiazem Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Diltiazem Sales in Volume by Country (2018-2023)
5.1.3 North America Diltiazem Sales in Value by Country (2018-2023)
5.2 North America Diltiazem Forecasted Market Size by Country
5.2.1 North America Diltiazem Sales in Volume by Country (2024-2029)
5.2.2 North America Diltiazem Sales in Value by Country (2024-2029)
6 Europe Diltiazem by Country
6.1 Europe Diltiazem Historic Market Size by Country
6.1.1 Europe Diltiazem Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Diltiazem Sales in Volume by Country (2018-2023)
6.1.3 Europe Diltiazem Sales in Value by Country (2018-2023)
6.2 Europe Diltiazem Forecasted Market Size by Country
6.2.1 Europe Diltiazem Sales in Volume by Country (2024-2029)
6.2.2 Europe Diltiazem Sales in Value by Country (2024-2029)
7 Asia-Pacific Diltiazem by Region
7.1 Asia-Pacific Diltiazem Historic Market Size by Region
7.1.1 Asia-Pacific Diltiazem Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Diltiazem Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Diltiazem Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Diltiazem Forecasted Market Size by Region
7.2.1 Asia-Pacific Diltiazem Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Diltiazem Sales in Value by Region (2024-2029)
8 Latin America Diltiazem by Country
8.1 Latin America Diltiazem Historic Market Size by Country
8.1.1 Latin America Diltiazem Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Diltiazem Sales in Volume by Country (2018-2023)
8.1.3 Latin America Diltiazem Sales in Value by Country (2018-2023)
8.2 Latin America Diltiazem Forecasted Market Size by Country
8.2.1 Latin America Diltiazem Sales in Volume by Country (2024-2029)
8.2.2 Latin America Diltiazem Sales in Value by Country (2024-2029)
9 Middle East and Africa Diltiazem by Country
9.1 Middle East and Africa Diltiazem Historic Market Size by Country
9.1.1 Middle East and Africa Diltiazem Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Diltiazem Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Diltiazem Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Diltiazem Forecasted Market Size by Country
9.2.1 Middle East and Africa Diltiazem Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Diltiazem Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bausch Health
10.1.1 Bausch Health Company Information
10.1.2 Bausch Health Introduction and Business Overview
10.1.3 Bausch Health Diltiazem Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bausch Health Diltiazem Products Offered
10.1.5 Bausch Health Recent Development
10.2 Teva
10.2.1 Teva Company Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Diltiazem Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Teva Diltiazem Products Offered
10.2.5 Teva Recent Development
10.3 Mylan
10.3.1 Mylan Company Information
10.3.2 Mylan Introduction and Business Overview
10.3.3 Mylan Diltiazem Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mylan Diltiazem Products Offered
10.3.5 Mylan Recent Development
10.4 Athenex
10.4.1 Athenex Company Information
10.4.2 Athenex Introduction and Business Overview
10.4.3 Athenex Diltiazem Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Athenex Diltiazem Products Offered
10.4.5 Athenex Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Diltiazem Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Diltiazem Products Offered
10.5.5 Pfizer Recent Development
10.6 Akorn
10.6.1 Akorn Company Information
10.6.2 Akorn Introduction and Business Overview
10.6.3 Akorn Diltiazem Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Akorn Diltiazem Products Offered
10.6.5 Akorn Recent Development
10.7 Sandoz
10.7.1 Sandoz Company Information
10.7.2 Sandoz Introduction and Business Overview
10.7.3 Sandoz Diltiazem Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sandoz Diltiazem Products Offered
10.7.5 Sandoz Recent Development
10.8 Sun Pharma
10.8.1 Sun Pharma Company Information
10.8.2 Sun Pharma Introduction and Business Overview
10.8.3 Sun Pharma Diltiazem Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sun Pharma Diltiazem Products Offered
10.8.5 Sun Pharma Recent Development
10.9 Hikma Pharmaceuticals
10.9.1 Hikma Pharmaceuticals Company Information
10.9.2 Hikma Pharmaceuticals Introduction and Business Overview
10.9.3 Hikma Pharmaceuticals Diltiazem Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Hikma Pharmaceuticals Diltiazem Products Offered
10.9.5 Hikma Pharmaceuticals Recent Development
10.10 Zydus Pharmaceuticals
10.10.1 Zydus Pharmaceuticals Company Information
10.10.2 Zydus Pharmaceuticals Introduction and Business Overview
10.10.3 Zydus Pharmaceuticals Diltiazem Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Zydus Pharmaceuticals Diltiazem Products Offered
10.10.5 Zydus Pharmaceuticals Recent Development
10.11 Par Pharmaceutical
10.11.1 Par Pharmaceutical Company Information
10.11.2 Par Pharmaceutical Introduction and Business Overview
10.11.3 Par Pharmaceutical Diltiazem Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Par Pharmaceutical Diltiazem Products Offered
10.11.5 Par Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Diltiazem Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Diltiazem Industrial Chain Analysis
11.4 Diltiazem Market Dynamics
11.4.1 Diltiazem Industry Trends
11.4.2 Diltiazem Market Drivers
11.4.3 Diltiazem Market Challenges
11.4.4 Diltiazem Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Diltiazem Distributors
12.3 Diltiazem Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
